The development and clinical application of PSMA-RGS represents an innovative and promising advancement in robot-assisted PCa surgery, specifically designed to enable the precise location of LNMs [13], thereby enhancing local disease control and improving oncological outcomes [16,28,29,30]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.